Join to View Full Profile
15 Claflin PathBrookline, MA 02445
Phone+1 617-731-9211
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bruce Ewenstein, MD is an oncologist in Brookline, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1983 - 1986
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1980 - 1983
Albert Einstein College of MedicineClass of 1980
Certifications & Licensure
MA State Medical License 1984 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 7 citationsEtranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.Michiel Coppens, Steven W Pipe, Wolfgang Miesbach, Jan Astermark, Michael Recht
The Lancet. Haematology. 2024-04-01 - Sex-specific NLRP3 activation in neutrophils promotes neutrophil recruitment and NETosis in the murine model of diffuse alveolar hemorrhage.Pierre-André Jarrot, Jiyoun Kim, William Chan, Lukas Heger, Nicolas Schommer
Frontiers in Immunology. 2024-01-01 - 1 citationsRisk of Intracranial Hemorrhage in Persons with Hemophilia A in the United States: Real-World Retrospective Cohort Study Using the ATHNdataset.Jianzhong Hu, Martin Chandler, Christopher Matthew Manuel, Jorge Caicedo, Michael Denne
Journal of Blood Medicine. 2024-01-01
Press Mentions
Results of a Randomized Phase III/IV Trial Comparing Intermittent Bolus Versus Continuous Infusion of Antihaemophilic Factor (Recombinant) in Adults with Severe or Moderately Severe Haemophilia A Undergoing Major Orthopaedic SurgeryMarch 27th, 2021
Shire to Present New Data at Isth 2017 to Advance the Standard of Care in HemophiliaJune 23rd, 2017
Shire to Present New Data at Isth 2017 to Advance the Standard of Care in HemophiliaJune 23rd, 2017- Join now to see all
